$ 18.5
Key Takeaways
Risk factor
Resilient to price shocks
Profitability factor
Greatly overvalued vs peers
About
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property...
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI
Target Price
The average target price of CLBT is 22 and suggests 17% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
